<?xml version="1.0" encoding="utf-8"?>
<modsCollection xmlns="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
<mods version="3.7">
      <titleInfo>
         <title>Report from the 2022 NIST Rapid Microbial Testing Methods (RMTM)
                Workshop</title>
      </titleInfo>
      <name type="personal" usage="primary">
         <namePart>Servetas, Stephanie.</namePart>
      </name>
      <name type="personal" xlink:href="(orcid):0000-0002-4924-4511">
         <namePart>Servetas, Stephanie.</namePart>
         <nameIdentifier>(orcid):0000-0002-4924-4511</nameIdentifier>
      </name>
      <name type="personal" xlink:href="(orcid):0000-0002-6980-3288">
         <namePart>Lin, Nancy.</namePart>
         <nameIdentifier>(orcid):0000-0002-6980-3288</nameIdentifier>
      </name>
      <name type="personal">
         <namePart>Chowdhury, Nadratun.</namePart>
      </name>
      <name type="personal" xlink:href="(orcid):0000-0002-6980-3288">
         <namePart>Jackson, Scott.</namePart>
         <nameIdentifier>(orcid):0000-0002-6980-3288</nameIdentifier>
      </name>
      <name type="personal" xlink:href="(orcid):0000-0003-4565-1176">
         <namePart>Kralj, Jason.</namePart>
         <nameIdentifier>(orcid):0000-0003-4565-1176</nameIdentifier>
      </name>
      <name type="personal">
         <namePart>Lin-Gibson, Sheng.</namePart>
      </name>
      <name type="personal">
         <namePart>Sanders, Melody.</namePart>
      </name>
      <name type="personal">
         <namePart>Eskandari, Tara.</namePart>
      </name>
      <name type="corporate">
         <namePart>National Institute of Standards and Technology (U.S.)</namePart>
         <namePart>Lab Name.</namePart>
      </name>
      <typeOfResource>text</typeOfResource>
      <genre authority="marcgt">encyclopedia</genre>
      <genre authority="rdacontent">text</genre>
      <originInfo>
         <place>
            <placeTerm type="code" authority="marccountry">ot</placeTerm>
         </place>
         <dateIssued encoding="marc">2023</dateIssued>
         <issuance>monographic</issuance>
      </originInfo>
      <originInfo eventType="publisher">
         <place>
            <placeTerm type="text">Gaithersburg, MD:</placeTerm>
         </place>
         <publisher>U.S. Dept. of Commerce, National Institute of Standards and
                Technology;</publisher>
         <dateIssued>2023-08-15.</dateIssued>
      </originInfo>
      <physicalDescription>
         <form authority="marcform">print</form>
         <form type="carrier" authority="rdacarrier">online resource</form>
         <extent>1 online resource : illustrations (color)</extent>
      </physicalDescription>
      <abstract displayLabel="Abstract">Safety and quality of advanced therapies, including cellular, gene,
                and tissue-engineered medical products, is paramount for success of these products.
                Sterility assurance testing confirming the absence of microbial contamination in
                advanced therapy products is critical to establishing safety before patient dosing.
                To date, culture-based compendial methods are employed as the gold standard for
                sterility testing of pharmaceutical products. However, for advanced therapy therapy
                products, the required cultivation period (e.g., 14 days or more) is incompatible
                with the short (e.g., 2 days) product shelf life and jeopardizes healthcare outcomes
                for critically ill patients who need these lifesaving therapies. Alternative rapid
                microbial testing methods are increasingly being evaluated to reduce test result
                turnaround time for advanced therapies, but are not yet widely adopted.NIST hosted a
                Rapid Microbial Testing Methods (RMTMs) Workshop on April 19, 2022 to address
                overarching themes relevant to the need to implement rapid microbial testing
                methods. The workshop's goals were to identify measurement challenges and hurdles to
                adopting RMTMs for advanced therapy products and to share and obtain feedback on
                future efforts of the RMTM Consortium. To this end, subject matter experts from
                relevant legal, regulatory, and scientific/technological spaces were invited to give
                presentations related to two broad themes: 1. Barriers and Potential Solutions to
                Adoption of RMTMs, and 2. Technologies and Tools for Rapid Microbial Detection.
                Invited speakers also participated in panel discussions that actively engaged
                audience members via live polling during facilitated and impromptu discussions. This
                virtual workshop collectively served as a venue for shared knowledge and learning on
                the state of the field for RMTMs and hurdles in their broad adoption, consequently
                benefiting a diverse group of stakeholders. Additionally, the workshop promoted
                greater awareness of the NIST RMTM Consortium and its activities. Summaries of the
                presentations, discussion, and poll results are presented within this
                report.</abstract>
      <note type="statement of responsibility">Stephanie L Servetas; Nancy J. Lin; Nadratun N. Chowdhury; Scott A.
                Jackson; Jason G. Kralj; Tara Eskandari; Melody Sanders; Sheng
                Lin-Gibson.</note>
      <note>August 2023.</note>
      <note>Title from PDF title page (viewed October 31, 2023).</note>
      <note type="bibliography">Includes bibliographical references.</note>
      <note type="venue">Approved by the NIST Editorial Review Board on 2023-05-19.</note>
      <note type="system details">Mode of access: World Wide Web.</note>
      <note type="system details">Systems requirements: Adobe Acrobat PDF reader.</note>
      <subject authority="lcsh">
         <topic>Standards</topic>
      </subject>
      <subject authority="lcsh">
         <topic>Regenerative medicine</topic>
      </subject>
      <subject authority="lcsh">
         <topic>Reference sources</topic>
      </subject>
      <subject authority="lcsh">
         <topic>Rapid methods (Microbiology)</topic>
      </subject>
      <subject authority="lcsh">
         <topic>Microbial contamination</topic>
      </subject>
      <subject>
         <topic>Workshop report</topic>
      </subject>
      <subject>
         <topic>Validation</topic>
      </subject>
      <subject>
         <topic>Sterility testing</topic>
      </subject>
      <subject>
         <topic>Microbial detection</topic>
      </subject>
      <subject>
         <topic>FDA regulations</topic>
      </subject>
      <subject>
         <topic>Consortium</topic>
      </subject>
      <subject>
         <topic>Cell and gene therapy</topic>
      </subject>
      <subject>
         <topic>Advanced therapy medicinal products</topic>
      </subject>
      <location>
         <url displayLabel="electronic resource" usage="primary display">https://doi.org/10.6028/NIST.SP.1292</url>
      </location>
      <relatedItem type="series">
         <titleInfo>
            <title>NIST special publication</title>
            <partNumber>1292</partNumber>
         </titleInfo>
      </relatedItem>
      <relatedItem type="series">
         <titleInfo>
            <title>NIST special publication; NIST special pub; NIST SP</title>
            <partNumber>1292</partNumber>
         </titleInfo>
      </relatedItem>
      <identifier type="oclc">1411253954</identifier>
      <recordInfo>
         <descriptionStandard>rda</descriptionStandard>
         <recordContentSource authority="marcorg">NBS</recordContentSource>
         <recordCreationDate encoding="marc">230803</recordCreationDate>
         <recordChangeDate encoding="iso8601">20240401111409.0</recordChangeDate>
         <recordIdentifier>991000614708808106</recordIdentifier>
         <recordOrigin>Converted from MARCXML to MODS version 3.7 using MARC21slim2MODS3-7.xsl
				(Revision 1.140 20200717)</recordOrigin>
         <languageOfCataloging>
            <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
         </languageOfCataloging>
      </recordInfo>
   </mods></modsCollection>
